| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |